Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med.2020;17:e1003346. doi:10.1371/journal.pmed.1003346 pmid:32960881
 Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. J Association of Medical Microbiology and Infectious Disease Canada, 2020; 5; 223-234.
 Everyone in the United Kingdom with symptoms now eligible for coronavirus tests. 18 May 2020. https://www.gov.uk/government/news/everyone-in-the-united-kingdom-with-symptoms-now-eligible-for-coronavirus-tests?utm_source=932565f9-f9d7-45ec-b964-d9f353f71948&utm_medium=email&utm_campaign=govuk-notifications&utm_content=daily
 Deeks JJ, Dinnes J, Takwoingi Y, et al., Cochrane COVID-19 Diagnostic Test Accuracy Group. Antibody tests for identification of current and past infection with SARS-CoV-2[PubMed]. Cochrane Database Syst Rev2020;6:CD013652.
 Shields A, Faustini SE, Perez-Toledo M, et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020; 75: 1089-1094
 Hains DS, Schwaderer AL, Carroll AE, et al. Asymptomatic seroconversion of immunoglobulins to SARS-CoV-2 in a pediatric dialysis unit. JAMA; 323:2424-2425 .
 Chen WQ., Lu CY, Wong TW, et al. Anti–SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China. Emerg Infect Dis. 2020; 11:89-94.
 Xu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med.2020; 26; 1193–1195.
 Sood N, Simon P, Ebner P, et al. Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. JAMA. 2020;323: 2425–2427.
 Pollán M, Pérez-Gómez B, Pastor-Barriuso R et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. The Lancet. 2020; 396; 535-544.
 Stringhini S, Wisniak A, Piumatti G. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. The Lancet. 2020; 396;313-319.
 Ward, H., Atchison, C., Whitaker, M. et al. SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nat Commun. 2021. 12, 905 https://doi.org/10.1038/s41467-021-21237-w
 Grant J, Wilmore S, McCann N et al. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Infect Control Hosp Epidemiol. 2021; 42; 212–214.
 Garcia-Basteiro, A.L., Moncunill, G., Tortajada, M. et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun.2020;11:3500
 Testing Strategy for Wales. 2021. https://gov.wales/sites/default/files/publications/2021-01/testing-strategy-for-wales.pdf
 Middleton J, Reintjes R, Lopes H. Meat plants—a new front line in the covid-19 pandemic. BMJ. 2020; 370:m2716
 Durad-Moreau Q, Adisesh A, Mackenzie G, et al. COVID-19 in meat and poultry facilities: a rapid review and lay media analysis. Centre for Evidence-Based Medicine. 2020. https://www.cebm.net/covid-19/what-explains-the-high-rate-of-sars-cov-2-transmission-in-meat-and-poultry-facilities-2/
 ECDC. COVID-19 clusters and outbreaks in occupational settings in the EU/EEA and the UK. 2020. https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-in-occupational-settings.pdf
 Scientific Pandemic Influenza Group on Behaviours. The impact of financial and other targeted support on rates of self-isolation or quarantine. 16th September 2020. https://www.gov.uk/government/publications/spi-b-impact-of-financial-and-other-targeted-support-on-rates-of-self-isolation-or-quarantine-16-september-2020  StatsWales. Ethnicity by area and ethnic group. 2021. https://statswales.gov.wales/Catalogue/Equality-and-Diversity/Ethnicity/ethnicity-by-area-ethnicgroup
 Nibbs L., Morawska L, Bell S. The risk of airborne influenza transmission in passenger cars. Epidemiology and Infection. 2012;140: 474-478
 Welsh Government. Travelling safely during the coronavirus pandemic: alert level 4 guidance for the public. 2021. https://gov.wales/travelling-safely-during-coronavirus-pandemic-guidance-public-html
 Mahase E. Covid-19: Innova lateral flow test is not fit for “test and release” strategy, say experts. 2020. BMJ; 371:m4469
 Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing. 8 Nov 2020. https://www.ox.ac.uk/sites/files/oxford/media_wysiwyg/UK%20evaluation_PHE%20Porton%20Down%20%20
 Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013; 177: 292-8.
 WHO. Population-based age-stratified seroepidemiological investigation protocol for COVID-19 virus infection. March 17, 2020. https://apps.who.int/iris/handle/10665/331656